167 related articles for article (PubMed ID: 22744426)
21. The role of TP53 and MDM2 polymorphisms in TP53 mutagenesis and risk of non-melanoma skin cancer.
Almquist LM; Karagas MR; Christensen BC; Welsh MM; Perry AE; Storm CA; Nelson HH
Carcinogenesis; 2011 Mar; 32(3):327-30. PubMed ID: 21123835
[TBL] [Abstract][Full Text] [Related]
22. A single-nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population.
Alshatwi AA; Hasan TN; Shafi G; Alsaif MA; Al-Hazzani AA; Alsaif AA
Fundam Clin Pharmacol; 2012 Jun; 26(3):438-43. PubMed ID: 21477265
[TBL] [Abstract][Full Text] [Related]
23. [TP53 gene polymorphisms and colorectal cancer risk in Chinese population].
Jia HR; He XL; Zhu ZZ; Jin XX; Wang AZ; Huang HY; Zhu J; Yu GB; Zhu GS
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1448-51. PubMed ID: 17785079
[TBL] [Abstract][Full Text] [Related]
24. TP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population.
Sameer AS; Shah ZA; Syeed N; Banday MZ; Bashir SM; Bhat BA; Siddiqi MA
Genet Mol Res; 2010 Apr; 9(2):651-60. PubMed ID: 20449797
[TBL] [Abstract][Full Text] [Related]
25. Genetic variants in germline TP53 and MDM2 SNP309 are not associated with early onset colorectal cancer.
Khan SA; Idrees K; Forslund A; Zeng Z; Rosenberg S; Pincas H; Barany F; Offit K; Laquaglia MP; Paty PB
J Surg Oncol; 2008 Jun; 97(7):621-5. PubMed ID: 18381604
[TBL] [Abstract][Full Text] [Related]
26. p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma.
Liu G; Cescon DW; Zhai R; Zhou W; Kulke MH; Ma C; Xu W; Su L; Asomaning K; Heist RS; Wain JC; Lynch TJ; Christiani DC
Dis Esophagus; 2010 Jan; 23(1):36-9. PubMed ID: 19302219
[TBL] [Abstract][Full Text] [Related]
27. MDM2 and TP53 Polymorphisms as Predictive Markers for Head and Neck Cancer in Northeast Indian Population: Effect of Gene-Gene and Gene-Environment Interactions.
Bhowmik A; Das S; Bhattacharjee A; Choudhury B; Naiding M; Deka S; Ghosh SK; Choudhury Y
Asian Pac J Cancer Prev; 2015; 16(14):5767-72. PubMed ID: 26320449
[TBL] [Abstract][Full Text] [Related]
28. Genetic polymorphisms of MDM2 and TP53 genes are associated with risk of nasopharyngeal carcinoma in a Chinese population.
Xiao M; Zhang L; Zhu X; Huang J; Jiang H; Hu S; Liu Y
BMC Cancer; 2010 Apr; 10():147. PubMed ID: 20398418
[TBL] [Abstract][Full Text] [Related]
29. Association of genetic polymorphisms in MDM2, PTEN and P53 with risk of esophageal squamous cell carcinoma.
Ma J; Zhang J; Ning T; Chen Z; Xu C
J Hum Genet; 2012 Apr; 57(4):261-4. PubMed ID: 22336889
[TBL] [Abstract][Full Text] [Related]
30. Association of p53 Arg72Pro and MDM2 SNP309 polymorphisms with glioma.
Zhang JN; Yi SH; Zhang XH; Liu XY; Mao Q; Li SQ; Xiong WH; Qiu YM; Chen T; Ge JW
Genet Mol Res; 2012 Oct; 11(4):3618-28. PubMed ID: 23096687
[TBL] [Abstract][Full Text] [Related]
31. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
Wang ML; Xu YX; Qian J; Wang FH
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
[TBL] [Abstract][Full Text] [Related]
32. The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies.
Tian X; Dai S; Sun J; Jiang S; Jiang Y
Oncotarget; 2017 Jan; 8(1):1156-1165. PubMed ID: 27901479
[TBL] [Abstract][Full Text] [Related]
33. MDM2 and P53 polymorphisms contribute together to the risk and survival of prostate cancer.
Xue L; Han X; Liu R; Wang Z; Li H; Chen Q; Zhang P; Wang Z; Chong T
Oncotarget; 2016 May; 7(22):31825-31. PubMed ID: 26025918
[TBL] [Abstract][Full Text] [Related]
34. Genetic polymorphisms of TP53 Arg72Pro and Pro47Ser among Egyptian patients with colorectal carcinoma.
Elsaid A; Zahran R; Elshazli R; El-Sayed A; Abou Samra M; El-Tarapely F; Abdel-Malak C
Arch Physiol Biochem; 2019 Jul; 125(3):255-262. PubMed ID: 29560751
[TBL] [Abstract][Full Text] [Related]
35. Significance of MDM2 and P14 ARF polymorphisms in susceptibility to differentiated thyroid carcinoma.
Zhang F; Xu L; Wei Q; Song X; Sturgis EM; Li G
Surgery; 2013 May; 153(5):711-7. PubMed ID: 23218882
[TBL] [Abstract][Full Text] [Related]
36. Association of rheumatoid arthritis with Mdm2 SNP309 and genetic evidence for an allele-specific interaction between MDM2 and p53 P72R variants: a case control study.
Assmann G; Voswinkel J; Mueller M; Bittenbring J; Koenig J; Menzel A; Pfreundschuh M; Roemer K; Melchers I
Clin Exp Rheumatol; 2009; 27(4):615-9. PubMed ID: 19772793
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of TP53 Pro72Arg and MDM2 SNP285-SNP309 polymorphisms in an Italian cohort of LFS suggestive patients lacking identifiable TP53 germline mutations.
Ponti F; Corsini S; Gnoli M; Pedrini E; Mordenti M; Sangiorgi L
Fam Cancer; 2016 Oct; 15(4):635-43. PubMed ID: 26956143
[TBL] [Abstract][Full Text] [Related]
38. [ASSOCIATION OF CERTAIN SINGLE NUCLEOTIDE POLYMORPHISM GENES OF APOPTOSIS SYSTEM WITH A RISK OF DEVELOPMENT OF COLORECTAL CANCER IN RUSSIAN POPULATION].
Alyeva MK; Zverev SY; Feldblyum IV; Noskova EY; Kanina AO; Markovich NI
Zh Mikrobiol Epidemiol Immunobiol; 2016 Sep; (5):72-80. PubMed ID: 30695351
[TBL] [Abstract][Full Text] [Related]
39. Do CDKN2 p16 540 C>G, CDKN2 p16 580 C>T, and MDM2 SNP309 T>G gene variants act on colorectal cancer development or progression?
Tuna G; Küçükhüseyin O; Arıkan S; Kaytan Sağlam E; Güler E; Cacına C; Oztop O; Turan S; Korkmaz G; Yaylım I
DNA Cell Biol; 2013 Jul; 32(7):400-8. PubMed ID: 23777425
[TBL] [Abstract][Full Text] [Related]
40. Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations.
Fang S; Krahe R; Lozano G; Han Y; Chen W; Post SM; Zhang B; Wilson CD; Bachinski LL; Strong LC; Amos CI
PLoS One; 2010 May; 5(5):e10813. PubMed ID: 20520810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]